Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has become one of the most discussed compounds in metabolic research and clinical medicine. Available as FDA-approved pharmaceuticals (Ozempic, Wegovy, Rybelsus) and as research-grade lyophilized powder, semaglutide requires different handling depending on its form.
This guide covers reconstitution of lyophilized research-grade semaglutide powder — the form that requires active reconstitution before use, as opposed to pre-filled pharmaceutical pens.
Semaglutide: Key Properties for Reconstitution
- Class: GLP-1 receptor agonist; synthetic analog of human GLP-1
- Molecular weight: Approximately 4,113 Da
- Solubility: Soluble in water at appropriate pH; BAC water is standard for reconstitution of lyophilized research powder
- Sensitivity: Relatively heat-stable compared to growth hormone peptides; however, all semaglutide preparations should be refrigerated
- Important difference from other peptides: Semaglutide is significantly more potent on a per-microgram basis than typical research peptides — dosing precision is especially critical. A miscalculation that matters little for a peptide like TB-500 can have pronounced effects with semaglutide.
Reconstitution Solvent
For lyophilized research semaglutide:
- Bacteriostatic water (BAC water) is the standard reconstitution solvent and is appropriate for multi-dose research notes.
- Some researchers prefer sterile water for initial aliquot preparation followed by freezing, to avoid any benzyl alcohol effects over extended storage.
- The pharmaceutical preparations (Ozempic, Wegovy) use proprietary buffer solutions — this guidance is specifically for lyophilized research powder, which does not include the pharmaceutical excipients.
Calculating Semaglutide Reconstitution
Semaglutide doses are expressed in milligrams (mg), unlike many peptides which are dosed in micrograms (mcg). Common research vial sizes are 5mg and 10mg.
Common Reconstitution for 5mg Vial
Add 2mL BAC water to 5mg semaglutide powder → 2.5mg/mL concentration.
Weekly dose reference (weekly dosing is standard — semaglutide has a ~7-day half-life due to its albumin-binding fatty acid chain):
- 0.25mg weekly dose = 0.10mL = 10 units on U-100 syringe
- 0.5mg weekly dose = 0.20mL = 20 units
- 1.0mg weekly dose = 0.40mL = 40 units
- 2.0mg weekly dose = 0.80mL = 80 units
Alternative: 5mg vial + 1mL water → 5mg/mL
- 0.25mg = 5 units
- 0.5mg = 10 units
- 1.0mg = 20 units
- 2.0mg = 40 units
Step-by-Step Reconstitution research notes
- Allow the lyophilized vial to come to room temperature before adding water — this reduces the temperature shock to the peptide.
- Wipe both the semaglutide vial and BAC water vial stoppers with alcohol wipes. Allow to dry completely.
- Draw your target volume of BAC water into an insulin syringe.
- Insert the needle into the semaglutide vial at a slight angle, directing the water down the wall of the glass vial — not directly onto the powder.
- Add water slowly. Do not plunge forcefully.
- Remove needle without pulling back on plunger.
- Gently swirl in slow circular motions. Semaglutide may take longer to dissolve than BPC-157 — 60–180 seconds of gentle swirling is normal.
- Do not shake. If resistance remains, let the vial sit for 5–10 minutes then resume gentle swirling.
- Solution should be clear, colorless to very slightly yellowish (a pale yellow is sometimes normal for semaglutide preparations).
- Label with date and concentration. Refrigerate immediately.
Storage Requirements
Lyophilized Semaglutide (Before Reconstitution)
- Refrigerated (2–8°C): Standard storage; stable to manufacturer expiry date
- Frozen: Can be stored frozen for longer periods; allow to thaw at room temperature before reconstitution
Reconstituted Semaglutide
- Refrigerated in BAC water: Stable for approximately 4–6 weeks (28–42 days)
- Frozen: For longer research notes, aliquot and freeze; minimize freeze-thaw cycles
- Room temperature: No more than a few hours — refrigerate at all times when possible
Dosing Precision — Why It Especially Matters for Semaglutide
Semaglutide's pharmacological effects are dose-dependent. The titration schedule used in clinical medicine (starting low and gradually increasing dose over weeks) exists for a reason: too high a dose too quickly causes significant gastrointestinal side effects. In research research notes, starting at the low end (0.25mg weekly) and titrating conservatively is the established approach.
Because doses are measured in single-digit milligrams, calculation errors have proportionally larger effects than with peptides dosed in hundreds of micrograms. Verify every calculation before drawing. Use a dedicated calculator to eliminate arithmetic errors. PepSync handles all semaglutide calculations automatically.
Semaglutide Half-Life: Dosing Frequency
Unlike most research peptides which are dosed daily or twice daily, semaglutide has an extended half-life of approximately 7 days. This results from its structural modification: a C-18 fatty acid chain attached via a linker creates albumin binding, dramatically extending circulation time compared to native GLP-1 (which has a half-life of minutes).
Weekly subcutaneous administration is the standard research notes. Injecting more frequently than weekly does not provide additional benefit and increases the risk of accumulation-related side effects.